je.st
news
Novartis sees Q4 profit rise 72 per cent to $2.1B without charges
2013-01-23 10:10:28| Biotech - Topix.net
The result is 72 per cent higher than the $1.21 billion net profit reported for the last quarter of 2011 when the Basel-based company took a $900-million charge after ending its clinical study into wider uses of the hypertension drug Tekturna.
Tags: without
rise
charges
profit
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||